Showing 2651-2660 of 7016 results for "".
Childhood Stroke: Risk Factors, Symptoms and Prognosis
https://reachmd.com/programs/focus-on-childrens-health/childhood-stroke-risk-factors-symptoms-and-prognosis/3657/Pediatric and adolescent stroke differ from adult stroke in frequency, presentation, management and prognosis. What causes childhood stroke, and how can we diagnose and treat the condition? Dr. E. Steve Roach, professor of pediatrics and neurology at the Ohio State University College of Medicine, anEnvironmentally Sustainable Building Initiatives in Health Care
https://reachmd.com/programs/clinicians-roundtable/environmentally-sustainable-building-initiatives-in-health-care/3190/Imagine a cancer center built without any of the toxic carcinogens commonly used in construction. It’s a concept that many experts in the health care industry believe could soon become a reality. In hospital architecture and building, what are other promising examples of environmental responsibility'Green' Resources for Smaller-Scale Medical Institutions
https://reachmd.com/programs/clinicians-roundtable/green-resources-for-smaller-scale-medical-institutions/3189/As society progresses toward greater levels of environmental sustainability, the healthcare industry will play a leading role. From major public institutions to smaller private practices, every contribution matters. How can solo practitioners incorporate these projects into their practice, and whatThe ENHANCE Study
https://reachmd.com/programs/lipid-luminations/the-enhance-study/2448/Dr. Kaskel welcomes Dr. Jerome Cohen to Lipid Luminations. Dr. Cohen is a cardiologist and professor of medicine and cardiology at St. Louis University where he also serves as the director of preventive cardiology. They will be delving into the controversial issues of The Enhance Study plus discussCan We Prevent Psoriatic Arthritis Before Diagnosis?
https://reachmd.com/programs/living-rheum/prevent-psoriatic-arthritis-before-diagnosis/51050/As our understanding of psoriatic arthritis deepens, we're starting to turn our attention toward intervention: preventing the disease before it progresses or is officially diagnosed. Tune in to hear Dr. Laura Coates discuss the evolving landscape of psoriatic arthritis prevention and interception, iEmerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://reachmd.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
https://reachmd.com/programs/cme/differentiating-neuromodulation-therapies-vns-dbs-ect-tms/35793/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
https://reachmd.com/programs/neurofrontiers/reviewing-the-treatment-landscape-for-duchenne-muscular-dystrophy/16066/Although there is currently no cure, what treatment options are available for our patients with Duchenne muscular dystrophy?Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://reachmd.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Gene Therapy, the Future of Eye Care?
https://reachmd.com/programs/medical-industry-feature/gene-therapy-future-of-eye-care/37246/While anti-VEGF therapy can deliver vision gains with consistent, frequent injections in clinical trials, it may be challenging to sustain this in real-world practice.1 Ocular gene therapy could be a potential option for patients with neovascular age-related macular degeneration if approved. With th